Pular para o conteúdo principal
Ranking Invest

IBRX - ImmunityBio, Inc.

Segmento: HealthcareImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Análise Ranking Invest

Valor de Mercado
$ 9.34 Bi
IVR
-0.36Índice proprietário de comparação relativa: -0,36.
IVR2
-0.24Leitura proprietária complementar: -24%.
MLL
-0.24Leitura proprietária complementar: -24%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

-$ 1.05 Bi

Dívida Líquida

-$ 75.67 Mi

L4T

-$ 992.36 Mi

MM4T

-563.15%

Indicadores Básicos

ROE

94.74%

Índices de Previsibilidade

Receita Líquida

F0.64

Lucro

C0.33

Margem

D0.91

Índices de Tendência

Receita Líquida

A10.68

Lucro

D1.30

Margem

B6.85

Índices de Endividamento

DIV/PAT

0.07

DIV/L4T

0.08

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.